Effects of aerobic-resistance training combine with green coffee consumption in overweight and obese women

Effects of aerobic-resistance training combine with green coffee consumption on insulin-like growth factor-1 (IGF-1), leptin, testosterone, cortisol, insulin resistance, glucose homeostasis, heart rate, metabolism, body composition, physical fitness, general health, appetite, anxiety and depression in overweight and obese women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017061422498N13

Enrollment

Registered

2017-06-21

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obese women. Obesity due to excess calories, Obesity, unspecified

Interventions

Intervention 1: Aerobic- resistance training Four sessions per week, each session consist of 20-30 min aerobic training at 65-75 percent of maximum heart rate and fallowing that eight movement at 65-8

Prevention

Aerobic- resistance training Four sessions per week, each session consist of 20-30 min aerobic training at 65-75 percent of maximum heart rate and fallowing that eight movement at 65-80 percent of on

Green coffee Six weeks, two 125 mg serving per day, dissolving in hot water

Eligibility

Sex/Gender

Female

Age

25 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: aged of 25-35 years; not have regular exercise training during last year; not have metabolic or orthopedic disease Exclusion criteria: using weight loss supplements or drug over the last six month; have special diet; absence for more than three sessions of training; not regular usage of green coffee

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Insulin-like growth factor-1 (IGF-1). Timepoint: 24 hour before and after interventions. Method of measurement: Serum levels using ELISA method (ng/ml).;Leptin. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (ng/ml).;Testosterone. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using photometric method (µg/dl).;Cortisol. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (µg/dl).;Fasting blood suger. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using photometric method (mg/dl).;Insulin. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (?mol/L).	—

Measure

Time frame

Insulin-like growth factor-1 (IGF-1). Timepoint: 24 hour before and after interventions. Method of measurement: Serum levels using ELISA method (ng/ml).;Leptin. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (ng/ml).;Testosterone. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using photometric method (µg/dl).;Cortisol. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (µg/dl).;Fasting blood suger. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using photometric method (mg/dl).;Insulin. Timepoint: 24 hour before and after interventions. Method of measurement: serum levels using ELISA method (?mol/L).

—

Secondary

Measure	Time frame
Insulin resistance. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using HOMA formula.;Heart rate. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of resting heart rate, systole and diastole blood pressure.;Basal and resting metabolic. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using BMR and RMR formula.;Body composition. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of weight, body mass index, body fat percent and waist to hip ratio.;Physical Fitness. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of aerobic power and anaerobic power.;General health. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using general health questionnaire.;Appetite. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using appetite questionnaire.;Anxiety and depression. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using questionnaire.	—

Measure

Time frame

Insulin resistance. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using HOMA formula.;Heart rate. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of resting heart rate, systole and diastole blood pressure.;Basal and resting metabolic. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using BMR and RMR formula.;Body composition. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of weight, body mass index, body fat percent and waist to hip ratio.;Physical Fitness. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using measurement of aerobic power and anaerobic power.;General health. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using general health questionnaire.;Appetite. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using appetite questionnaire.;Anxiety and depression. Timepoint: Before intervention and six weeks after intervention. Method of measurement: Using questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafiseh Karimnezhad, Zivar Hasani, Afshin Saket

Islamic Azad University Rasht Branch

dr.ramin.shabani@gmail.com+98 13 3375 2715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026